header ADC report 540x680@2x
NICE INSIGHT REPORT

Antibody–Drug Conjugate, ADC: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking

Coming August, 2024
  • 2024 CDMO pricing data for competitive benchmarking
  • ADC manufacturing process and areas of innovation
  • 30+ company profiles for a comprehensive CDMO landscape
  • 100+ pages of ADC market insights and breakthroughs
  • Projections on one of the most anticipated markets
header ADC report 540x680@2x

Key market insights for innovators, CDMOs and investors in the Antibody–Drug Conjugate industry.

01 analysis icon 65x65@2x

The market trends that decision makers need to know

Our complete Market Analysis uses scientific insights from PhDs and researchers to provide an exhaustive overview of the ADC industry. From the emergence of ADCs as cancer treatments to how big pharma has penetrated ADC, stay ahead of market trends with our report.
02 benchmarking icon 65x65@2x

Exclusive pricing data to benchmark against peers

Keep your sales team ahead of the curve by using our primary data for an accurate pricing comparison. Our Market Analysis provides a manufacturing process and strategic pricing study designed to give CDMOs a competitive edge.

Coming August, 2024

Market intelligence for research, manufacturing and pricing all in one report.

The Antibody–Drug Conjugate, ADC: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking provides

01 pricing data icon 65x65@2x
Current pricing data for benchmarking in the emerging market
02 technology icon 65x65@2x
Manufacturing technologies that are invaluable for ADC manufacturers
03 market projections icon 65x65@2x
Hundreds of pages of market insights for your sales team
04 profiles icon 65x65@2x
30+ company profiles of top CDMOs in the U.S., Europe and Asia
05 pipeline icon 65x65@2x-1
Pipeline overview and the approval and regulatory landscape
06 scientific analysis icon 65x65@2x
Value-chain analysis and the unique complexities in ADC production

Over 700 hours of data collection and analysis —
interviews with CDMO owners, KOLs and industry experts

Table of Contents

Executive Summary

Overview of the report

Study Methodology

Section I:

Background on Antibody–Drug Conjugates

Section II:

ADCs Market Overview

  • 1. ADCs Market Growth and Projection
  • 2. Market Opportunities and Challenges
  • 3. Approval and development Overview
  • 4. Market Segmentation by Disease Application

Section III:

Clinical Trials – Past and Present

Section IV:

ADCs CDMO Market Outlook

Section V:

ADC Manufacturing Technologies

Section VI:

Unique Considerations and Complexities in ACD Development and Manufacturing

Section VII:

Strategic Pricing Study

Section VIII:

ADCs CDMO Profiles

ADC report form@2x
Coming August, 2024
Request a quote for the Antibody–Drug Conjugate, ADC: 2024 Market Insight report

ADC report form@2x